scispace - formally typeset
S

Sangeeta Shah

Researcher at University of Queensland

Publications -  48
Citations -  1021

Sangeeta Shah is an academic researcher from University of Queensland. The author has contributed to research in topics: Population & Heart failure. The author has an hindex of 12, co-authored 44 publications receiving 835 citations. Previous affiliations of Sangeeta Shah include MedStar Washington Hospital Center & Ochsner Medical Center.

Papers
More filters
Journal ArticleDOI

Best practices in managing transition to adulthood for adolescents with congenital heart disease: The transition process and medical and psychosocial issues: A Scientific Statement from the American Heart Association

TL;DR: In the absence of structured programs to guide this transition, there is often delayed or inappropriate care, improper timing of the transfer of care, and undue emotional and financial stress on the patients, their families, and the healthcare system as mentioned in this paper.
Journal Article

Clinical implications of left atrial enlargement: a review.

TL;DR: It is suggested that echocardiographically determined left atrial size may become an important clinical risk identifier in preclinical CV disease and should be assessed as a part of routine comprehensive eChocardiographic evaluation.
Journal ArticleDOI

Impact of echocardiographic left ventricular geometry on clinical prognosis.

TL;DR: Evidence supporting the benefits of LVH regression is examined, as well as evidence regarding the risk of CR progressing to LVH, as opposed to normalization of CR.
Journal ArticleDOI

Prognostic Implications of Left Ventricular Hypertrophy.

TL;DR: In this article, the authors discuss appropriate techniques for accurate analysis, underlying pathophysiology, and the contributions from various risk factors, and examine the effect of therapy to reduce LVH and the resultant clinical outcomes.
Journal ArticleDOI

Current Perspectives on Left Ventricular Geometry in Systemic Hypertension

TL;DR: The relationship between HTN and LV geometric changes is reviewed with a focus on diagnostic approach, epidemiology, pathophysiology, prognostic effect, and LV response to anti-HTN therapy and its impact on CVD risk reduction.